Click Here to return To Results

 

Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study Lancet 372:1463-1472, Kappos,L.,et al, 2008 See this aricle in Pubmed Article Abstract The anti-inflammatory effects and favourable safety profile of BG00012 warrant further long-term phase III studies in large patient groups.

Related Tags

(click to filter results - removes previous filter) efficacy fumarate gadolinium MRI MRI,abnormal MRI,contrast enhanced multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,treatment of neuroprotective agents nonsteroidal anti-inflammatory drug safety

Click Here to return To Results